东宝生物(300239.SZ)：上半年净利润3696.73万元 同比下降28.00%

Core Viewpoint - Dongbao Biological (300239.SZ) reported a decline in revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 369 million yuan, a year-on-year decrease of 16.93% [1] - The net profit attributable to shareholders was 36.97 million yuan, down 28.00% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 33.44 million yuan, reflecting a 27.41% decline compared to the previous year [1] - Basic earnings per share were reported at 0.0629 yuan [1]